Health ❯ Healthcare

Clinical Trials

Drug Development Phase 3 Trials Drug Efficacy Patient Outcomes Phase III Trials Research Studies Randomized Controlled Trials Efficacy Studies Cancer Research Cancer Treatment

Pfizer, Valneva Lyme Vaccine Shows Over 70% Protection but Misses Primary Goal

Regulators now weigh strong protection against a missed primary benchmark.

Apogee to Report 52-Week Phase 2 Data for Zumilokibart in Atopic Dermatitis Today

RTW Buys $116 Million of Cogent Biosciences as Kynam Trims $48 Million Stake

Peer-Reviewed Study Shows Lab-Grown Oesophagus Restores Swallowing in Pigs

FDA Approves First Therapy for Acquired Hypothalamic Obesity, Expanding Rhythm’s Imcivree

FDA Approves Nivolumab Plus AVD as First-Line Therapy for Advanced Hodgkin Lymphoma

FDA Clears 7.2‑mg Wegovy as India Enters Generic Semaglutide Era

FDA Clears J&J’s Icotyde, First Oral IL-23 Psoriasis Therapy for Ages 12 and Up

HER2 Drug Trio Extends Survival in Phase II Study of Breast Cancer Leptomeningeal Metastasis

Serina Therapeutics Shares Jump After Private Placement to Raise Up to $63.3 Million

Arvinas’ ARV-102 Hits >50% LRRK2 Degradation in Phase 1 Parkinson’s Trial

UCSF-Led Study Engineers CAR-T Cells In Vivo, Clearing Tumors in Mice

For Third Time, FDA Rejects Aldeyra’s Dry-Eye Drug Reproxalap Over Efficacy

Artelo Secures Fully Funded Investigator-Led Glaucoma Trial With Belfast Health Trust

Ligand-Based OSM CAR-T Shows Preclinical Efficacy Against Osteosarcoma

ACC/AHA Overhaul Cholesterol Care With Earlier Screening, New Risk Tool and Clear LDL Targets

Atrogi Begins Dosing in 8-Week Human Study of GRK2-Biased β2 Agonist ATR-258

Structure’s Oral Obesity Pill Delivers 16.3% Placebo-Adjusted Weight Loss in Phase 2

PrimeC Shows Safety and Potential Benefit in ALS Phase 2b as FDA Authorizes Phase 3

Large Trial Finds No Acute COVID Benefit From Vitamin D, Hints at Fewer Long COVID Symptoms